Skip to content
DraconiticResearch
Search Sources API
186,541 studies31 sourcesUpdated 48 min ago
Peer-reviewedLicence not statedAnnals of Oncology

GLP-1 receptor agonist use and cancer risk in obese nondiabetic adults

  • Arthur Heng-Cheng Hsu
  • Pedro Tomas Ramirez1
  • Y.-H. Chang2
  • Y.C. Chiang3
  • María Clara Santía4
  • Tommaso Meschini5
  • Paula Mateo-Kubach1
  • A. Suri1
  • A.A. Kamat6
6 affiliations
  1. 1Department of Obstetrics and Gynecology, Houston Methodist Hospital, Houston Methodist Neal Cancer Center, Houston, Texas, USA
  2. 2Institute of Statistics, National Yang Ming Chiao Tung University, Hsinchu, Taiwan
  3. 3Department of Obstetrics and Gynecology, National Taiwan University Hospital, Taipei, Taiwan; Department of Obstetrics and Gynecology, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Obstetrics and Gynecology, National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu, Taiwan
  4. 4Department of Gynecology, Hospital Italiano of Buenos Aires, Buenos Aires, Argentina
  5. 5Department of Obstetrics and Gynecology, Women's and Children's Del Ponte Hospital, University of Insubria, Varese, Italy
  6. 6Department of Obstetrics and Gynecology, Houston Methodist Hospital, Houston Methodist Neal Cancer Center, Houston, Texas, USA. Electronic address: [email protected]
Open at sourcePDFDOICite

Related

  1. Dietary intake and weight loss in obese adults during GLP-1 receptor agonist treatment
    A Ramel
    The European Journal of Public HealthPeer-reviewedCC BY-NC 4.0Full textPharmacology & toxicologyPMCEurope PMC
  2. GLP-1 Receptor Agonist Use Among Adults With Diabetes and Cancer History
    Olinto Linares-Perdomo, Damon Klebe, Fumiko Chino +1
    JAMA Network OpenPeer-reviewedCC BY 4.0Endocrinology & metabolismCrossref
  3. Patterns of GLP-1 Receptor Agonist Initiation Compared With Other Glucose-Lowering and Anti-Obesity Therapies Among Older Adults
    J. D. Brooks, M. A. Donahue, A. ElHassan +6
    medRxivPreprintAll rights reservedFull textEndocrinology & metabolismmedRxiv
  4. GLP-1 Receptor Agonist Initiation Is Associated With Excess Skeletal Muscle Loss in Adults With Diabetes: A Prospective Population-Based MRI Study
    E. Stambollxhiu, J. Luebberstedt, M. Kumpf +9
    medRxivPreprintCC BY-NC-NDFull textEndocrinology & metabolismmedRxiv
  5. Association of GLP-1 Receptor Agonist Use with Thyroid Outcomes in Adults with Type 2 Diabetes.
    Ching-Chung Hsiao, Ming-Hsien Tsai, Jian-Yu Jhu +4
    International journal of medical sciencesPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC

Cite

BibTeXRIS
BibTeX
@article{hsu2026glp1,
  title = {{GLP-1 receptor agonist use and cancer risk in obese nondiabetic adults}},
  author = {Arthur Heng-Cheng Hsu and Pedro Tomas Ramirez and Y.-H. Chang and Y.C. Chiang and María Clara Santía and Tommaso Meschini and Paula Mateo-Kubach and A. Suri and A.A. Kamat},
  journal = {Annals of Oncology},
  year = {2026},
  month = jun,
  doi = {10.1016/j.annonc.2026.04.013},
  url = {https://doi.org/10.1016/j.annonc.2026.04.013},
}
RIS
TY  - JOUR
TI  - GLP-1 receptor agonist use and cancer risk in obese nondiabetic adults
AU  - Arthur Heng-Cheng Hsu
AU  - Pedro Tomas Ramirez
AU  - Y.-H. Chang
AU  - Y.C. Chiang
AU  - María Clara Santía
AU  - Tommaso Meschini
AU  - Paula Mateo-Kubach
AU  - A. Suri
AU  - A.A. Kamat
PY  - 2026
DA  - 2026/06/07
JO  - Annals of Oncology
DO  - 10.1016/j.annonc.2026.04.013
UR  - https://doi.org/10.1016/j.annonc.2026.04.013
SN  - 0923-7534
SN  - 1569-8041
ER  -